Posts by Mark Darwin
Regency Steel Asia chairman fined S$350,000 for false trading of Hiap Hoe, Hotel Grand Central shares
THE Monetary Authority of Singapore (MAS) imposed a civil penalty of S$350,000 on Gui Boon Sui for conducting false and unauthorised trading of shares in Hiap Hoe and Hotel Grand Central. Gui is currently listed as the chairman of Regency Steel Asia. The steel solution provider was formed in 2004, following the acquisition of…
Read MoreSmart glasses enter new era with sleeker designs, lower prices
PRODUCERS of hi-tech connected eyewear are multiplying their innovations with increasingly discreet models in an attempt to make a difference in a highly competitive – and fast-emerging – market. Live translation, GPS, cameras: glasses are quickly adopting new functionalities. “There are so many of these smart wearables, and more of them are going on your…
Read MoreTop Asian oil buyers in turmoil after sweeping Russian sanctions
REFINERS, tanker operators, traders and port executives across Asia were scrambling on Monday (Jan 13) to manage the fallout from the US’s most aggressive sanctions on Russia’s oil industry to date, and the impact on major importers China and India. The two countries have been the main beneficiaries of cut-price Russian crude since the invasion…
Read MoreTop Asian oil buyers in turmoil after sweeping US sanctions on Russia’s oil industry
REFINERS, tanker operators, traders and port executives across Asia were scrambling on Monday (Jan 13) to manage the fallout from the United States’ most aggressive sanctions on Russia’s oil industry to date, and the impact on major importers China and India. The two countries have been the main beneficiaries of cut-price Russian crude since the…
Read MoreMacquarie investing arm hires Gabriel Ho for South-east Asia push
MACQUARIE Group has hired a new managing director as part of a push in South-east Asia for the firm’s investing arm. Macquarie Asset Management appointed Gabriel Ho to expand its coverage of the region, the company said in a statement on Monday (Jan 13). Ho was formerly a partner at South-east Asia focused private equity…
Read MoreMiyoshi’s Sin to continue as CEO despite accounting irregularity
MIYOSHI’s board of directors is of the view that chief executive and executive director of the company Andrew Sin should continue in his role. This comes despite Sin being fined S$22,400 by Singapore’s State Court last Friday (Jan 10), for failing to recognise an impairment loss in the company’s financial statements for the fiscal year…
Read MoreSingapore shares open lower on Monday; STI down 0.3%
SINGAPORE equities began Monday (Jan 13) in negative territory, tracking losses in global markets last Friday. As at 9.01 am, the Straits Times Index (STI) fell 11.05 points or 0.3 per cent to 3,790.51. Across the broader market, losers outnumbered gainers 76 to 33, after 36.9 million securities worth S$43.6 million changed hands. Medical technology…
Read MoreA*Star, Grand Venture Technology to develop manufacturing platform as company’s semiconductor business gains pace
GRAND Venture Technology (GVT) and the Agency for Science, Technology and Research (A*Star) will be working together to develop a customised manufacturing platform for advanced ceramics, as the mainboard-listed company continues to make leaps in its semiconductor business. On Monday (Jan 13), the manufacturing service provider said the tie-up will allow GVT to capture opportunities…
Read MoreStocks to watch: Stoneweg E-Reit, Grand Venture Technology
THE following companies saw new developments that may affect trading of their securities on Monday (Jan 13): Stoneweg European Real Estate Investment Trust (Stoneweg E-Reit): The Reit received a “BBB-” long-term issuer credit rating from S&P Global Ratings, on the expectation of stable operational performance and cash flow over the next two years. On Friday…
Read MoreJohnson & Johnson is in talks to buy US$10 billion biotech Intra-Cellular
JOHNSON & Johnson (J&J) is in talks to acquire Intra-Cellular Therapies, a biopharmaceutical company focused on treatments for central nervous system disorders, sources familiar with the matter said. A deal could be reached as soon as this week, according to the sources, who asked not to be identified discussing confidential information. While discussions are ongoing,…
Read More